Filing Details
- Accession Number:
- 0001127602-21-019273
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2021-06-04 16:51:50
- Reporting Period:
- 2021-06-02
- Accepted Time:
- 2021-06-04 16:51:50
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 885590 | Bausch Health Companies Inc. | BHC | Pharmaceutical Preparations (2834) | 000000000 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1681871 | Christina Ackermann | 400 Somerset Corporate Boulevard Bridgewater NJ 08807 | Evp And General Counsel | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Shares, No Par Value | Acquisiton | 2021-06-02 | 60,345 | $14.38 | 227,103 | No | 4 | M | Direct | |
| Common Shares, No Par Value | Acquisiton | 2021-06-02 | 60,853 | $15.32 | 287,956 | No | 4 | M | Direct | |
| Common Shares, No Par Value | Disposition | 2021-06-02 | 121,198 | $31.83 | 166,758 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Shares, No Par Value | Non-Qualified Stock Options (right to purchase) | Disposition | 2021-06-02 | 60,345 | $0.00 | 60,345 | $14.38 |
| Common Shares, No Par Value | Non-Qualified Stock Options (right to purchase) | Disposition | 2021-06-02 | 60,853 | $0.00 | 60,853 | $15.32 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | 2027-03-01 | No | 4 | M | Direct | |
| 0 | 2028-03-07 | No | 4 | M | Direct |
Footnotes
- The price in Column 4 reflects the average weighted sale price for the transactions aggregated on this Form 4. The sales price per share reported on this Form 4 range from $31.61 to $32.11. The reporting person will provide to the Commission, the issuer and any stockholder, upon request, full information regarding the number of shares sold at each separate price.
- The options vest in equal installments on each of the first three anniversaries of the date of grant.
Billionaire Hedge Funds
